Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bio-Path Holdings, Inc. (BPTH)

3.04   0.2 (7.04%) 05-16 00:51
Open: 2.88 Pre. Close: 2.84
High: 3.05 Low: 2.88
Volume: 33,228 Market Cap: 22(M)
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.05 - 3.07 3.07 - 3.09
Low: 2.84 - 2.86 2.86 - 2.88
Close: 3.01 - 3.04 3.04 - 3.07

Technical analysis

as of: 2022-05-13 4:36:47 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.04     One year: 4.61
Support: Support1: 2.68    Support2: 2.22
Resistance: Resistance1: 3.46    Resistance2: 3.95
Pivot: 3
Moving Average: MA(5): 2.98     MA(20): 2.98
MA(100): 3.55     MA(250): 4.75
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 32.9     %D(3): 37.8
RSI: RSI(14): 46.4
52-week: High: 8.61  Low: 2.68
Average Vol(K): 3-Month: 69 (K)  10-Days: 53 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BPTH ] has closed below upper band by 43.0%. Bollinger Bands are 37.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 15 May 2022
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Down 29.7% in April - Defense World

Fri, 13 May 2022
Bio-Path (NASDAQ:BPTH) Coverage Initiated by Analysts at - Defense World

Tue, 10 May 2022
Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022 - Bluefield Daily Telegraph

Thu, 05 May 2022
Bio-Path (NASDAQ:BPTH) Research Coverage Started at - Defense World

Sat, 30 Apr 2022
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Up 60.1% in April - Defense World

Wed, 27 Apr 2022
Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 7 (M)
Shares Float 7 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 5.8 (%)
Shares Short 96 (K)
Shares Short P.Month 88 (K)

Stock Financials

EPS -1.56
EPS Est Next Qtl -0.02
EPS Est This Year -0.08
EPS Est Next Year -0.11
Book Value (p.s.) 3.55
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -30.4
Return on Equity (ttm) -51.6
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.45
Qtrly Earnings Growth 0
Operating Cash Flow -10 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -1.96
PEG Ratio 0
Price to Book value 0.85
Price to Sales 0
Price to Cash Flow -2.2

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-01-17
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.